RWE, Market Access, Pricing and Reimbursement 2020 Americas is a conference dedicated to a unique platform and a dynamic approach to key trends, methodologies and insights on market access, real world data.
Topics
- Health Technology Assessment in Health-Care
- Strategies for one of pharma industry’s greatest challenge: market access
- Growth of biosimilars and importance of RWE for orphan drugs and rare diseases
- Real word evidence and randomized control trials, close the gap
- Challenges and opportunities in pricing, reimbursement and patient access
- Emerging markets: the impact on global pricing and commercialization
- Looking to the future: what is there to expect?
- Risk sharing agreements, benefits and challenges
Who should Attend
Senior attendees with job titles such as:
- Vice Presidents
- Members of Boards
- Head/Chief
- Directors
- Senior Managers
